Gene · 80331
Papers3,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Economic models of community-based falls prevention: a systematic review with subsequent commissioning and methodological recommendations. | BMC Health Serv Res | 2022 | 35255898 | PubTator, text mining | PubMed |
| Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease). | Front Cell Dev Biol | 2022 | 35252181 | PubTator, text mining | PubMed |
| Mid-Liver Stage Arrest of Plasmodium falciparum Schizonts in Primary Porcine Hepatocytes. | Front Cell Infect Microbiol | 2022 | 35252038 | PubTator, text mining | PubMed |
| One-step electrodeposition of a polypyrrole/NiO nanocomposite as a supercapacitor electrode. | Sci Rep | 2022 | 35246573 | PubTator, text mining | PubMed |
| Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. | Cell Mol Life Sci | 2022 | 35244787 | PubTator, text mining | PubMed |
| Enhanced fluorescence/magnetic resonance dual imaging and gene therapy of liver cancer using cationized amylose nanoprobe. | Mater Today Bio | 2022 | 35243295 | PubTator, text mining | PubMed |
| Culturally relevant/responsive and sustaining pedagogies in science education: theoretical perspectives and curriculum implications. | Cult Stud Sci Educ | 2022 | 35228853 | PubTator, text mining | PubMed |
| Compounds targeting GPI biosynthesis or N-glycosylation are active against Plasmodium falciparum. | Comput Struct Biotechnol J | 2022 | 35222844 | PubTator, text mining | PubMed |
| ATG Ubiquitination Is Required for Circumsporozoite Protein to Subvert Host Innate Immunity Against Rodent Malaria Liver Stage. | Front Immunol | 2022 | 35222391 | PubTator, text mining | PubMed |
| Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease. | Int J Mol Sci | 2022 | 35216492 | PubTator, text mining | PubMed |
| An Attenuated HSV-1-Derived Malaria Vaccine Expressing Liver-Stage Exported Proteins Induces Sterilizing Protection against Infectious Sporozoite Challenge. | Vaccines (Basel) | 2022 | 35214758 | PubTator, text mining | PubMed |
| Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases. | Pharmaceutics | 2022 | 35214155 | PubTator, text mining | PubMed |
| Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics. | Pharmaceutics | 2022 | 35214130 | PubTator, text mining | PubMed |
| The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes? | Front Immunol | 2022 | 35211123 | PubTator, text mining | PubMed |
| N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases. | Antioxidants (Basel) | 2022 | 35204298 | PubTator, text mining | PubMed |
| Report from the 27th (Virtual) Meeting on Toxinology, "Toxins: Mr Hyde or Dr Jekyll?", Organized by the French Society of Toxinology, 9-10 December 2021. | Toxins (Basel) | 2022 | 35202137 | PubTator, text mining | PubMed |
| Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger. | Nat Commun | 2022 | 35190534 | PubTator, text mining | PubMed |
| Plasmodium Circumsporozoite Protein Enhances the Efficacy of Gefitinib in Lung Adenocarcinoma Cells by Inhibiting Autophagy via Proteasomal Degradation of LC3B. | Front Cell Dev Biol | 2022 | 35186935 | PubTator, text mining | PubMed |
| Hypoxia-ischemia-mediated effects on neurodevelopmentally regulated cold-shock proteins in neonatal mice under strict temperature control. | Pediatr Res | 2022 | 35184138 | PubTator, text mining | PubMed |
| The light chain of the L9 antibody is critical for binding circumsporozoite protein minor repeats and preventing malaria. | Cell Rep | 2022 | 35172158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80331/papers?page=44